Article
FDA Outlines "Plausible Mechanism" Approval Pathway For Personalized Therapies, But Significant Questions Remain
FDA Commissioner Martin Makary and Center for Biologics Evaluation and Research Director Vinay Prasad recently published an article in the New England Journal of Medicine ("NEJM") outlining the guiding principles of a new...
Ropes & Gray LLP